| Similar Articles |
|---|
 |
The Motley Fool
October 31, 2007
Brian Lawler |
Adams On-and-Off With the FDA A new compound gets delayed, but the drugmaker still raises earnings guidance, and shares rise. Investors, take note.   |
The Motley Fool
December 29, 2006
Brian Lawler |
Adams Tries to Fix Another Cough Adams Respiratory Therapeutics announced a new drug application filed. Investors, take note. |
The Motley Fool
August 25, 2006
Ralph Casale |
Adams Coughs Up Some Profits Adams Respiratory Therapeutics isn't suffering any off-seasonal ills. Investors, take note. |
The Motley Fool
June 26, 2006
Stephen D. Simpson |
J&J Makes an Expensive Deal J&J announced that it has reached an agreement with Pfizer to acquire the latter's consumer health-care business for $16.6 billion in cash. Consumer health is a fine business line, but is it worth this much money? Investors, take note. |
Chemistry World
July 28, 2014
Phillip Broadwith |
Reckitt Benckiser to spin out US pharma arm Consumer health firm Reckitt -- Benckiser plans to spin off its US pharmaceutical division, whose primary product is heroin-substitute Suboxone. |
Chemistry World
February 14, 2013
Andrew Turley |
BMS sells OTC drugs for $482m UK consumer goods giant Reckitt Benckiser has struck a $482 million deal to buy from Bristol-Myers Squibb rights to a range of over-the-counter drugs in parts of Latin America, including Brazil and Mexico. |
The Motley Fool
June 8, 2010
Rich Smith |
3 Stocks Dilbert Would Love to Hate Here's a few more "bad guys" you can bet on -- Comcast, Pfizer, and ExxonMobil for example. |
BusinessWeek
January 24, 2005
Laura Cohn |
Why It Pays To Reinvent The Mop U.K.-based Reckitt-Benckiser isn't a household word, but it's a cleaning-products superstar. Its stock has more than doubled since 2000, to $29. |
BusinessWeek
July 29, 2010
Sarah Shannon |
Britain's Reckitt Benckiser Goes Shopping The purchase of SSL International, maker of Durex condoms and Scholl foot products, is meant to shore up the consumer product company's revenue growth. |
Chemistry World
November 23, 2012
Andrew Turley |
Schiff seals deal with Reckitt The billion-dollar tussle between German healthcare giant Bayer and UK consumer products firm Reckitt Benckiser over Schiff Nutrition has been resolved with Reckitt winning out. |
Registered Rep.
February 27, 2009
David A. Geracioti |
New Obama Tax Increases Are Bad Enough for Wealthy, but under Democratic Sponsored House Bills, Estate Planning Will Be Turned Upside Down Looks like financial advisors catering to the affluent will have a new disaster to talk about: Obama's tax hikes and closing of personal exemptions and itemized deductions. |
